GE ECHOPAC

K072952 · General Electric Co. · LLZ · Nov 16, 2007 · Radiology

Device Facts

• Record ID: K072952
• Device Name: GE ECHOPAC
• Applicant: General Electric Co.
• Product Code: LLZ · Radiology
• Decision Date: Nov 16, 2007
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 892.2050
• Device Class: Class 2
• Attributes: Software as a Medical Device, Pediatric

Intended Use

The GE EchoPAC workstation is indicated for diagnostic review and analysis of ultrasound images acquired under various modes of operation including B, M, Color M modes, Color, Power, Pulsed & CW Doppler modes, Code Pulse, Harmonic and Realtime 3D. Specific clinical applications include: Fetal; Abdominal; Urology (including prostate); Pediatric; Small Organ (breast, testes, thyroid); Neonatal Cephalic; Adult Cephalic; Cardiac (adult and pediatric); Musculo-skeletal Conventional; Peripheral Vascular; Transesophageal (TEE); Transrectal (TR); Transvaginal (TV); and Intraoperative (abdominal, thoracic, & vascular).

Device Story

GE EchoPAC is an ultrasound image analysis and review workstation; optimized for images acquired via GE Vivid diagnostic ultrasound systems. Device functions as a post-acquisition review tool for clinicians; enabling analysis of B, M, Color M, Color, Power, Pulsed/CW Doppler, Coded Pulse, Harmonic, and Realtime 3D modes. Used in clinical settings; operated by healthcare professionals. Output allows clinicians to review and analyze diagnostic images to support clinical decision-making. Benefits include efficient management and review of ultrasound data.

Clinical Evidence

No clinical data required. Bench testing performed to confirm conformance to design specifications, software development standards, and system compatibility. Reliability evaluated within the intended network environment.

Technological Characteristics

Ultrasound image analysis workstation; software-based. Conforms to 21 CFR 820, ISO 9001:2000, and ISO 13485:2000. Operates on computer hardware certified to applicable safety standards. Connectivity via network integration for image management.

Indications for Use

Indicated for diagnostic review and analysis of ultrasound images in patients requiring fetal, abdominal, urological, pediatric, small organ, neonatal/adult cephalic, cardiac, musculoskeletal, peripheral vascular, transesophageal, transrectal, transvaginal, or intraoperative ultrasound assessment.

Regulatory Classification

Identification

A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.

Special Controls

*Classification.* Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

Predicate Devices

• GE Vivid 7 Diagnostic Ultrasound with EchoPAC (K060542)

Submission Summary (Full Text)

{0}------------------------------------------------

K072952

Special 510(k) Premarket Notification GE EchoPAC Ultrasound Workstation - Medical Image Management Device October 17, 2007

## Attachment B:

NOV 1 2005

# Summary of Safety and Effectiveness

Prepared in accordance with 21 CFR Part 807.92(c).

GE Healthcare

General Electric Company P.O. Box 414, Milwaukee, WI 53201

#### Section a):

| Submitter: | GE Medical Systems, Ultrasound and Primary Care Diagnostics<br>PO Box 414<br>Milwaukee, WI 53201 |
|-----------------|------------------------------------------------------------------------------------------------------|
| Contact Person: | Allen Schuh,<br>Manager, Ultrasound Regulatory Affairs<br>Telephone: [phone]; Fax: [phone] |
| Date Prepared: | October 17, 2007 |

2. Device Name: GE EchoPAC™ Ultrasound Image Workstation System, Image Processing, Radiological , 21 CFR 892.2050, 90-LLZ
3. Marketed Device: GE Vivid 7 Diagnostic Ultrasound with EchoPAC - K060542 Ultrasonic Pulsed Doppler Imaging System, 21 CFR 892.1550, 90-IYN4. Device Description: The GE EchoPAC is an Ultrasound image Analysis and Review Workstation optimized for ultrasound images that are acquired primarily via the GE Vivid family of diagnostic ultrasound systems. It is sold either with computer hardware only with hardware specifications.

5. Indications for Use: For diagnostic review and analysis of ultrasound images acquired under various modes of operation including B, M, Color M modes, Color, Power, Pulsed & CW Doppler modes, Coded Pulse, Harmonic and Realtime 3D. Specific clinical applications include: Fetal; Abdominal; Urology (including prostate); Pediatric; Small Organ (breast, testes, thyroid); Neonatal and Adult Cephalic; Cardiac (adult and pediatric); Peripheral Vascular; Musculo-skeletal Conventional; Transesophageal (TEE); Transrectal (TR); Transvaginal (TV); and Intraoperative (abdominal, thoracic, & vascular)

6. Comparison with Predicate Device: The GE EchoPAC™ is the same device previously cleared as an accessory to the Vivid 7 ultrasound system under K060542. It has the technological characteristics, key safety and effectiveness features, physical design, construction, and materials, and has essentially the same intended uses and post acquisition characteristics as the Vivid 7 ultrasound system.

#### Section b):

1. Non-clinical Tests: The device has been evaluated for conformance to its design specifications and applicable industry standards for software development. It is further verified for system compatibility with the devices with which it communicates. Computer hardware is certified to applicable safety standards.

2. Clinical Tests: None required to confirm safety and effectiveness. However, evaluation in a clinical setting is performed to help assure reliability within the intended network environment.

3. Conclusion: Intended uses and other key features of the device are consistent with traditional clinical practice. FDA quidelines and established methods of handling patient examination images and data. The design and development process of the manufacturer conforms with 21 CFR 820, ISO 9001:2000 and ISO 13485:2000 quality systems. The device conforms to applicable medical device safety standards and compliance is verified through internal and independent quality system audit. PACS devices and medical information management systems in general have accumulated a long history of safe and effective performance. Therefore, it is the opinion of GE Healthcare that the GE EchoPAC™ is substantially equivalent with respect to safety and effectiveness to devices currently cleared for market.

{1}------------------------------------------------

#### DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles a stylized eagle or bird with three wing-like shapes above a wavy line.

#### Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

#### NOV 1 6 2007

Mr. Allen Schuh Manager, Ultrasound Regulatory Affairs General Electric Company GE Medical Systems, Ultrasound and Primary Care Diagnostics, LLC 9900 Innovation Drive WAUWATOSA WI 53226

Re: K072952

Trade/Device Name: GE EchoPACTM Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: October 17, 2007 Received: October 18, 2007

Dear Mr. Schuh:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{2}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter.

| 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 |
|-----------------|----------------------------------|--------------|
| 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 |
| 21 CFR 892.xxxx | (Radiology) | 240-276-0120 |
| Other | | 240-276-0100 |

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Nancy Brogdon

Nancy C. B rogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

Page 2

{3}------------------------------------------------

Special 510(k) Premarket Notification Special 310(K) Promance Netical Image Management Device October 17, 2007

## Attachment E

### Indications for Use

510(k) Number (if known):

K072952

Device Name: GE EchoPAC™

Indications For Use:

The GE EchoPAC workstation is indicated for diagnostic review and analysis of ultrasound images acquired under various modes of operation including B, M, Color M modes, Color, Power, Pulsed & CW Doppler modes, Code Pulse, Harmonic and Realtime 3D. Specific clinical applications Fetal; Abdominal; Urology (including prostate); include: Pediatric; Small Organ (breast, testes, thyroid); Neonatal Cephalic; Adult Cephalic; Cardiac (adult and pediatric); Musculo-skeletal Conventional; Peripheral Vascular; Transesophageal (TEE); Transrectal (TR); Transvaginal (TV); and Intraoperative (abdominal, thoracic, & vascular).

Prescription Use XXX (Part 21 CFR 801 Subpart D) AND/OR

Over The Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

logu h'Whing

(Division Division of Reproductive. Abdominal ar Radiological Devices 510(k) Number

E-1